Drug Shortage Report for STALEVO

Last updated on 2020-01-21 History
Report ID 101765
Drug Identification Number 02305933
Brand name STALEVO
Common or Proper name STALEVO FCT 50MG 100'S
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) ENTACAPONE CARBIDOPA LEVODOPA
Strength(s) 200MG 12.5MG 50MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100'S
ATC code N04BA
ATC description DOPAMINERGIC AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2019-12-19
Actual start date 2019-12-19
Estimated end date 2020-01-15
Actual end date 2020-01-20
Shortage status Resolved
Updated date 2020-01-21
Company comments Supply interruption
Health Canada comments
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2020-01-21 English Compare
v10 2020-01-20 French Compare
v9 2020-01-20 English Compare
v8 2020-01-20 English Compare
v7 2020-01-17 French Compare
v6 2020-01-17 English Compare
v5 2020-01-10 French Compare
v4 2020-01-10 English Compare
v3 2019-12-20 English Compare
v2 2019-12-19 French Compare
v1 2019-12-19 English Compare